Lilly To Offer Direct-To-Employer Programs
Eli Lilly and Co. is preparing a new direct-to-employer model that will allow companies to offer coverage for its obesity medications, including Zepbound, beginning in early 2026.
Read MoreEli Lilly and Co. is preparing a new direct-to-employer model that will allow companies to offer coverage for its obesity medications, including Zepbound, beginning in early 2026.
Read MoreTo fight cheaper alternative versions of its weight loss drug, Eli Lilly & Co. have lowered prices of Zepbound vials.
Read MoreEli Lilly has partnered with Amazon Pharmacy to deliver medicine as part of its service, LillyDirect Pharmacy Solutions.
Read MoreEli Lilly and Company has announced LillyDirect, a new digital healthcare experience for patients in the United States living with obesity, migraine and diabetes.
Read More